dexfenfluramine Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
anorexics 832 3239-44-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dexfenfluramine
  • (+)-Fenfluramine
  • D-Fenfluramine
  • dextrofenfluramine
  • (S)-Fenfluramine
  • dexfenfluramine hydrochloride
  • dexfenfluramine HCl
The S-isomer of FENFLURAMINE. It is a serotonin agonist and is used as an anorectic. Unlike fenfluramine, it does not possess any catecholamine agonist activity.
  • Molecular weight: 231.26
  • Formula: C12H16F3N
  • CLOGP: 3.30
  • LIPINSKI: 0
  • HAC: 1
  • HDO: 1
  • TPSA: 12.03
  • ALOGS: -4.03
  • ROTB: 5

Drug dosage:

DoseUnitRoute
30 mg O

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 1.85 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Hosey CM, Chan R, Benet LZ
BA (Bioavailability) 89 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 11 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 11 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.66 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 14 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
Jan. 1, 1970 YEAR INTRODUCED

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC A08AA04 ALIMENTARY TRACT AND METABOLISM
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
Centrally acting antiobesity products
CHEBI has role CHEBI:50949 serotonin uptake inhibitor
CHEBI has role CHEBI:35941 serotonergic agonist
CHEBI has role CHEBI:50507 appetite depressant
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018490 Serotonin Agents
MeSH PA D017366 Serotonin Receptor Agonists

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Obesity indication 414916001 DOID:9970
Alcoholism contraindication 7200002
Glaucoma contraindication 23986001 DOID:1686
Hypertensive disorder contraindication 38341003 DOID:10763
Diabetes mellitus type 2 contraindication 44054006 DOID:9352
Diabetes mellitus type 1 contraindication 46635009 DOID:9744
Pulmonary hypertension contraindication 70995007 DOID:6432

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.22 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
5-hydroxytryptamine receptor 6 GPCR Ki 5.04 PDSP
Alpha-1B adrenergic receptor GPCR Ki 6.85 PDSP
5-hydroxytryptamine receptor 7 GPCR Ki 5.26 PDSP
Sodium-dependent serotonin transporter Transporter Ki 6.18 PDSP
5-hydroxytryptamine receptor 2C GPCR Ki 5.79 PDSP
5-hydroxytryptamine receptor 2A GPCR Ki 5.61 PDSP
5-hydroxytryptamine receptor 1B GPCR Ki 5.72 PDSP
5-hydroxytryptamine receptor 1D GPCR Ki 5.90 PDSP
Muscarinic acetylcholine receptor M3 GPCR Ki 5.33 PDSP
Alpha-2C adrenergic receptor GPCR Ki 6.71 PDSP
Alpha-2B adrenergic receptor GPCR Ki 6.62 PDSP
Muscarinic acetylcholine receptor M1 GPCR Ki 5.73 PDSP
Alpha-2A adrenergic receptor GPCR Ki 6.27 PDSP
5-hydroxytryptamine receptor 1A GPCR Ki 6.08 PDSP
Beta-1 adrenergic receptor GPCR Ki 6.00 PDSP
Muscarinic acetylcholine receptor M4 GPCR Ki 5.16 PDSP
Muscarinic acetylcholine receptor M2 GPCR Ki 5.58 PDSP
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 6.66 DRUG MATRIX
Alpha-1A adrenergic receptor GPCR Ki 6.57 WOMBAT-PK
5-hydroxytryptamine receptor 2B GPCR Ki 5.38 WOMBAT-PK
5-hydroxytryptamine receptor 1A GPCR IC50 5.47 CHEMBL

External reference:

IDSource
4024029 VUID
N0000022034 NUI
C0011786 UMLSCUI
D03713 KEGG_DRUG
322047008 SNOMEDCT_US
4024029 VANDF
004127 NDDF
3268 RXNORM
412366002 SNOMEDCT_US
d04006 MMSL
66265 PUBCHEM_CID
CHEBI:59730 CHEBI
CHEMBL248702 ChEMBL_ID
E35R3G56OV UNII
5818 INN_ID
3239-45-0 SECONDARY_CAS_RN
DB01191 DRUGBANK_ID
D020372 MESH_DESCRIPTOR_UI
CHEMBL1887891 ChEMBL_ID

Pharmaceutical products:

None